[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @gordon_analysis Andrew Gordon Andrew Gordon posts on X about $onc, covalent, what is, status the most. They currently have XXX followers and X posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::1652176085130379264/interactions)  - X Week XXX +305% - X Month XXXXX +105% - X Months XXXXXX +161% - X Year XXXXXX +194% ### Mentions: X [#](/creator/twitter::1652176085130379264/posts_active)  - X Week X no change - X Month XX +39% - X Months XX +135% - X Year XXX +28% ### Followers: XXX [#](/creator/twitter::1652176085130379264/followers)  - X Week XXX +2.40% - X Month XXX +3.30% - X Months XXX +53% - X Year XXX +161% ### CreatorRank: undefined [#](/creator/twitter::1652176085130379264/influencer_rank)  ### Social Influence **Social category influence** [cryptocurrencies](/list/cryptocurrencies) XXXX% **Social topic influence** [$onc](/topic/$onc) #4, [covalent](/topic/covalent) 12.5%, [what is](/topic/what-is) 12.5%, [status](/topic/status) 12.5%, [$4503t](/topic/$4503t) 12.5%, [$path](/topic/$path) 12.5%, [strong](/topic/strong) 12.5%, [$nuvb](/topic/$nuvb) 12.5%, [$lu](/topic/$lu) XXXX% **Top accounts mentioned or mentioned by** [@annexonbio](/creator/undefined) **Top assets mentioned** [One Cash (ONC)](/topic/$onc) [UiPath, Inc. (PATH)](/topic/$path) ### Top Social Posts Top posts by engagements in the last XX hours "$onc Is this morning's drop in price due to the 12/3 FDA approval of pirtobrutinib for adults with r/r cll or sll who have previously been treated with a covalent BTK inhibitor" [X Link](https://x.com/gordon_analysis/status/1996978167869837668) 2025-12-05T16:21Z XXX followers, XXX engagements "@annexonbio What is the status of tge BLA filing for ANX005 with the FDA What is the status of European collaborations for ANX005 and ANX007 Given ANX007's favorable position in Europe has ANNX discussed European collaborations with Apellis and Astellas" [X Link](https://x.com/gordon_analysis/status/1983577121034273038) 2025-10-29T16:50Z XXX followers, XXX engagements "$PATH - is a $20+ stock. Excellent earnings report. Strong guidance. Collaborations with major tech companies. Disruptive product. Reasonable market capitalization to sales ratio. Add $PATH to $ONC and $NUVB for 2026" [X Link](https://x.com/gordon_analysis/status/1996538193425162438) 2025-12-04T11:12Z XXX followers, XXX engagements "$lu Oct. XX 2025 $X calls Volume: 5774" [X Link](https://x.com/gordon_analysis/status/1970278464742986226) 2025-09-23T00:06Z XXX followers, XXX engagements "$onc I think that pirtobrutinib as a second line treatment will not do much if any harm to ONC. As a second line treatment patients on Brukinsa would have to develop resistance then go to pirtobrutinib. If they develop resistance then they would be off Brukinsa anyway" [X Link](https://x.com/gordon_analysis/status/1997066548582699071) 2025-12-05T22:12Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@gordon_analysis Andrew GordonAndrew Gordon posts on X about $onc, covalent, what is, status the most. They currently have XXX followers and X posts still getting attention that total XX engagements in the last XX hours.
Social category influence cryptocurrencies XXXX%
Social topic influence $onc #4, covalent 12.5%, what is 12.5%, status 12.5%, $4503t 12.5%, $path 12.5%, strong 12.5%, $nuvb 12.5%, $lu XXXX%
Top accounts mentioned or mentioned by @annexonbio
Top assets mentioned One Cash (ONC) UiPath, Inc. (PATH)
Top posts by engagements in the last XX hours
"$onc Is this morning's drop in price due to the 12/3 FDA approval of pirtobrutinib for adults with r/r cll or sll who have previously been treated with a covalent BTK inhibitor"
X Link 2025-12-05T16:21Z XXX followers, XXX engagements
"@annexonbio What is the status of tge BLA filing for ANX005 with the FDA What is the status of European collaborations for ANX005 and ANX007 Given ANX007's favorable position in Europe has ANNX discussed European collaborations with Apellis and Astellas"
X Link 2025-10-29T16:50Z XXX followers, XXX engagements
"$PATH - is a $20+ stock. Excellent earnings report. Strong guidance. Collaborations with major tech companies. Disruptive product. Reasonable market capitalization to sales ratio. Add $PATH to $ONC and $NUVB for 2026"
X Link 2025-12-04T11:12Z XXX followers, XXX engagements
"$lu Oct. XX 2025 $X calls Volume: 5774"
X Link 2025-09-23T00:06Z XXX followers, XXX engagements
"$onc I think that pirtobrutinib as a second line treatment will not do much if any harm to ONC. As a second line treatment patients on Brukinsa would have to develop resistance then go to pirtobrutinib. If they develop resistance then they would be off Brukinsa anyway"
X Link 2025-12-05T22:12Z XXX followers, XXX engagements
/creator/twitter::gordon_analysis